ND 420

Drug Profile

ND 420

Alternative Names: ND-420

Latest Information Update: 03 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nang Kuang Pharmaceutical
  • Class Antineoplastics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Oesophageal cancer

Most Recent Events

  • 28 Mar 2017 Nang Kuang Pharmaceutical terminates phase II trial in Oesophageal cancer (Combination therapy, Neoadjuvant therapy) in Taiwan (NCT02017600)
  • 02 Mar 2016 No development reported - Phase-II for Oesophageal cancer (Combination therapy, Neoadjuvant therapy) in Taiwan (unspecified route)
  • 07 Feb 2014 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top